Position in VKTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$5,570,237
+$938,917 QoQ
Shares Held
142,790
+0.3% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2
of 34 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $11,845,532 across 11 Biotechnology names. VKTX ranks #1 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
This page
|
142,790 | $5,570,237 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
85,989 | $2,702,634 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
19,613 | $1,535,109 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,989 | $987,995 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
789 | $491,973 | |
| 6 | INCY |
Incyte Corp
|
2,120 | $240,323 | |
| 7 | PRQR |
ProQR Therapeutics N.V.
|
64,000 | $119,040 | |
| 8 | ABVX |
Abivax S.A.
|
643 | $85,686 |
All Filings in VKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,570,237 | 142,790 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $4,631,320 | 142,327 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,050,440 | 143,560 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,159,223 | 120,214 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,723,533 | 65,039 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $957,595 | 39,652 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||